• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Cmed Raises $10M to Advance EDC

Cmed Raises $10M to Advance EDC

December 15, 2008
CenterWatch Staff

UK-based contract research organization (CRO) Cmed has raised almost $10 million in growth capital—funds that will be used to advance the company’s electronic data capture (EDC) system and the company’s brand worldwide.

The funding, from European investment firm Scottish Equity Partners (SEP), comes as an investment in Cmed shares. Cmed will have access to further funds should the company need it, according to Cmed CEO David Connelly.

Up until recently, Cmed was known simply as a CRO with EDC capabilities, and the company used profits from its CRO division to fund the development of its Timaeus EDC platform. However, Timaeus has gained increasing interest from pharmaceutical companies as a stand-alone product.

“Interest in our Timaeus system as a next generation system has really been starting to grow over this last 12 months,” Connelly said. “We recognized that we needed to take on capital if we were going to grow the company to the next level.”

Timaeus, according to the company, is the first EDC system to enable multiple types of data capture (e.g., paper, Web, advanced wireless) within a single trial with full data manage ment capabilities.

“If you look at the competitors out there, they’ve either had an old CDMS—an old Clinical Data Management System—and they’ve tried to add on withWeb electronic data capture or they’ve built aWeb electronic data capture system and they’re trying to build the system backwards to provide data management capabilities as well,” Connelly said. “Our view was that you really shouldn’t do that.What we decided to do was build a brand new architecture that’s quite different from the current systems out there.”

Founded in 1999, Cmed will continue to be a CRO, but Connelly predicts the CRO and technology divisions will become increasingly separate as more pharmaceutical companies license the Timaeus technology.

Other CROs are beginning to express interest in Cmed’s Timaeus technology, as well.

“We’re not averse to providing [other CROs] the technology, because we recognize as a CRO with just under 250 people we cannot support the big global studies or meet the demands of some of the clients. In fact, some [sponsors] are suggesting to CROs that they come to us, especially for large or difficult studies,” he said.

Headquartered in the UK with offices in the United States and Romania, Cmed will use the funding to promote the company’s brand worldwide. Connelly said the company has been called the “best kept secret in clinical research,” but he hopes to change that in 2009.

“Because of growing interest in Africa, we are currently exploring the possibility of a presence in Africa.We have just recruited our first person in Singapore so we may well put a technical support hub in Singapore. Longer term, we have plans to expand further into Central and Eastern Europe and also into South America,” Connelly said.

In 2009, the company will open up at least one additional U.S. office and plans to add to its senior management team to facilitate the company’s growth.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing